Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognitionE Pizzi, A Tramontano, L Tomei, et al.
Journal of Virology|December 16, 1998
Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis virusesG Filocamo, L Pacini, C Nardi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1999
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virusS Bressanelli, L Tomei, A Roussel, et al.
Biochemistry|June 24, 1998
Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage productsP Ingallinella, S Altamura, E Bianchi, et al.
Biochemistry|August 26, 1998
Design of selective eglin inhibitors of HCV NS3 proteinaseF Martin, N Dimasi, C Volpari, et al.
Journal of Virology|October 6, 1997
Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoiresN Dimasi, F Martin, C Volpari, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIα complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranesV Reghellin, L Donnici, S Fenu, et al.
Protein Engineering|May 1, 1997
Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 proteaseF Martin, C Volpari, C Steinkuhler, et al.
The Journal of Biological Chemistry|March 4, 2000
Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexesS Di Marco, M Rizzi, C Volpari, et al.
Journal of Biomolecular NMR|June 30, 2001
Measurement of homonuclear three-bond J(H(N)Halpha) coupling constants in unlabeled peptides complexed with labeled proteins: application to a decapeptide inhibitor bound to the proteinase domain of the NS3 protein of hepatitis C virus (HCV)D O Cicero, G Barbato, U Koch, et al.
Pageof 7